SynthesisFrontiers in endocrinology2022

Comparison of efficacy and safety of three novel hypoglycemic agents in patients with severe diabetic kidney disease: A systematic review and network meta-analysis of randomized controlled trials.

Yijun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.